Efficacy and safety of anagrelide as a first‐line drug in cytoreductive treatment‐naïve essential thrombocythemia patients in a real‐world setting.

Autor: Ito, Tomoki1 (AUTHOR) itot@hirakata.kmu.ac.jp, Hashimoto, Yoshinori2 (AUTHOR), Tanaka, Yasuhiro3 (AUTHOR), Nakaya, Aya1 (AUTHOR), Fujita, Shinya1 (AUTHOR), Satake, Atsushi1 (AUTHOR), Nakanishi, Takahisa1 (AUTHOR), Konishi, Akiko1 (AUTHOR), Hotta, Masaaki1 (AUTHOR), Yoshimura, Hideaki1 (AUTHOR), Ishii, Kazuyoshi1 (AUTHOR), Hashimoto, Akiko3 (AUTHOR), Kondo, Toshinori4 (AUTHOR), Omura, Hiromi2 (AUTHOR), Shinzato, Isaku3 (AUTHOR), Tanaka, Takayuki2 (AUTHOR), Nomura, Shosaku1 (AUTHOR)
Zdroj: European Journal of Haematology. Aug2019, Vol. 103 Issue 2, p116-123. 8p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje